Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-30 @ 12:17 AM
Study NCT ID:
NCT07414602
Status:
RECRUITING
Last Update Posted:
2026-03-18
First Post:
2026-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
Sponsor:
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-03
First Submit QC Date:
None
Study First Post Date:
2026-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-16
Last Update Post Date:
2026-03-18
Last Update Post Date Type:
ACTUAL